Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Descriptive Study of COVID-19 Among Children With Chronic Renal Diseases in Qatar

NCT05275595 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT05275595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05275595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Descriptive Study of COVID-19 Among Children With Chronic Renal Diseases in Qatar
Lead sponsor
Hamad Medical Corporation
Phase
Observational
Overall status
Completed
Start date
March 1, 2022
Completion date
December 31, 2022
Enrollment
1,300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, chronic kidney diseases, chronic renal failure in children, covid-19 infection, covid-19 pandemic